Technical Analysis for AXGT - Axovant Sciences Ltd.

Grade Last Price % Change Price Change
grade F 7.19 -4.39% -0.33
AXGT closed down 4.39 percent on Friday, May 24, 2019, on 2.0 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Down Down
See historical AXGT trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Boomer Sell Setup Bearish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Hammer Candlestick Bullish -4.39%
Wide Bands Range Expansion -4.39%
Oversold Stochastic Weakness -4.39%
Lower Bollinger Band Walk Weakness -3.36%
New 52 Week Low Weakness -3.36%

Older signals for AXGT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Axovant Sciences is a clinical-stage gene therapy company focused on developing a pipeline of innovative product candidates for debilitating neurological and neuromuscular diseases. The company’s current pipeline of gene therapy candidates targets GM1 gangliosidosis, GM2 gangliosidosis (including Tay-Sachs disease and Sandhoff disease), Parkinson’s disease, oculopharyngeal muscular dystrophy (OPMD), amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Axovant is focused on accelerating product candidates into and through clinical trials with a team of experts in gene therapy development and through external partnerships with leading gene therapy organizations.
Rare Diseases Gene Therapy Amyotrophic Lateral Sclerosis Parkinson’s Disease Lipid Storage Disorders Oculopharyngeal Muscular Dystrophy Axovant Sciences Frontotemporal Dementia Gangliosidosis Gm1 Gm1 Gangliosidosis Gm2 Gangliosidoses Gm 2 Gangliosidosis Gm2 Gangliosidosis Neurological And Neuromuscular Diseases Sandhoff Disease Tay Sachs Disease Tay–Sachs Disease
Is AXGT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 52.72
52 Week Low 7.0
Average Volume 198,058
200-Day Moving Average 12.5649
50-Day Moving Average 9.2122
20-Day Moving Average 8.2505
10-Day Moving Average 7.595
Average True Range 0.6746
ADX 50.12
+DI 4.6984
-DI 22.4135
Chandelier Exit (Long, 3 ATRs ) 7.5762
Chandelier Exit (Short, 3 ATRs ) 9.0238
Upper Bollinger Band 9.6562
Lower Bollinger Band 6.8448
Percent B (%b) 0.12
BandWidth 34.075511
MACD Line -0.5295
MACD Signal Line -0.4763
MACD Histogram -0.0532
Fundamentals Value
Market Cap 773.1 Million
Num Shares 108 Million
EPS -2.10
Price-to-Earnings (P/E) Ratio -3.42
Price-to-Sales 0.00
Price-to-Book 2.66
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.17
Resistance 3 (R3) 8.21 7.93 8.00
Resistance 2 (R2) 7.93 7.68 7.91 7.95
Resistance 1 (R1) 7.56 7.53 7.42 7.52 7.89
Pivot Point 7.28 7.28 7.21 7.26 7.28
Support 1 (S1) 6.91 7.03 6.77 6.87 6.49
Support 2 (S2) 6.63 6.88 6.61 6.43
Support 3 (S3) 6.26 6.63 6.38
Support 4 (S4) 6.22